Known targets — ChEMBL curated mechanism
CACNA1CCACNA1DCACNA1FCACNA1SDPP4HTR1BHTR1D
The experimentally established mechanism targets of Benzoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.74 |
| ▸ | DAO | P14920 | 1/20 | 0.74 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.74 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | CES1 | P23141 | 3/20 | 0.61 |
| ▸ | CES2 | O00748 | 2/20 | 0.61 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.61 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.56 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.56 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.56 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.56 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.56 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.56 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.56 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.56 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzoic Acid SCHEMBL27206572 | 0.97 | TSHR (0.70) | TSHRDAONAPRTNR4A2ALDH1A1 | |
| Benzoic Acid SCHEMBL15485652 | 0.97 | NR4A2 (0.74) | TSHRDAONAPRTNR4A2ALDH1A1 | |
| Adipic Acid SCHEMBL11024842 | 0.90 | HDAC3 (0.69) | TSHRDAONAPRTNR4A2ALDH1A1 | |
| Adipic Acid SCHEMBL7202698 | 0.90 | HDAC3 (0.69) | TSHRDAONAPRTNR4A2ALDH1A1 | |
| Glutarate SCHEMBL7758803 | 0.90 | TSHR (0.67) | TSHRDAONAPRTNR4A2ALDH1A1 | |
| Terephthalic Acid SCHEMBL3902498 | 0.89 | TSHR (0.71) | TSHRDAONAPRTNR4A2ALDH1A1 | |
| Benzoic Acid SCHEMBL1419301 | 0.89 | LMNA (0.58) | TSHRDAONAPRTNR4A2ALDH1A1 | |
| Benzoic Acid SCHEMBL27978458 | 0.89 | — | — | |
| Sebacic Acid SCHEMBL3695791 | 0.88 | HDAC3 (0.73) | TSHRDAONAPRTNR4A2ALDH1A1 | |
| Benzoic Acid SCHEMBL8653124 | 0.88 | TSHR (0.64) | TSHRDAONAPRTNR4A2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104430311-A | Active bactericidal medicine as well as preparation method and special equipment thereof | BEIJING HYGIENE AND HEALTHCARE INOVATION TECHNOLOGY CO LTD | 2015-03-25 | — | — | CN | claimed |
| US-8269023-B2 | Process for preparation of duloxetine hydrochloride | LUPIN LTD. (IN) | 2012-09-18 | — | — | US | claimed |
| US-20100105925-A1 | NOVEL PROCESS FOR PREPARATION OF DULOXETINE HYDROCHLORIDE | LUPIN LIMITED (IN) | 2010-04-29 | — | — | US | claimed |
| EP-2132192-A2 | NOVEL PROCESS FOR PREPARATION OF DULOXETINE HYDROCHLORIDE | Lupin Limited (IN) | 2009-12-16 | — | — | EP | claimed |
| WO-2008107911-A2 | NOVEL PROCESS FOR PREPARATION OF DULOXETINE HYDROCHLORIDE | LUPIN LIMITED (IN) | 2008-09-12 | — | — | WO | claimed |
| US-5346694-A | Acid stable gel stick antiperspirant compositions and process for making them | THE PROCTER & GAMBLE COMPANY (US) | 1994-09-13 | — | — | US | claimed |
| CN-118530412-A | Binder for negative electrode, negative electrode slurry, negative electrode, and lithium battery | 深圳好电科技有限公司 | 2024-08-23 | — | — | CN | disclosed |
| CN-112742427-B | Startup method of hydrogenation catalyst | 中国石油化工股份有限公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-112742428-B | Preparation method of vulcanized hydrogenation catalyst | 中国石油化工股份有限公司 | 2023-02-03 | — | — | CN | disclosed |
| EP-2828369-B1 | LIQUID CLEANING AND DISINFECTING COMPOSITIONS | PROCTER & GAMBLE (US) | 2019-01-02 | — | — | EP | disclosed |
| EP-1695708-B1 | Highly concentrated minoxidil composition | STIEFEL RES AUSTRALIA PTY LTD (AU) | 2018-02-28 | — | — | EP | disclosed |
| EP-2827709-B1 | LIQUID CLEANING AND DISINFECTING COMPOSITIONS | PROCTER & GAMBLE (US) | 2017-09-06 | — | — | EP | disclosed |
| CN-104136498-B | Novel liquid organopolysiloxanes and use thereof | 道康宁东丽株式会社 | 2017-06-20 | — | — | CN | disclosed |
| EP-2132192-A2 | NOVEL PROCESS FOR PREPARATION OF DULOXETINE HYDROCHLORIDE | Lupin Limited (IN) | 2009-12-16 | — | — | EP | disclosed |
| WO-2008107911-A2 | NOVEL PROCESS FOR PREPARATION OF DULOXETINE HYDROCHLORIDE | LUPIN LIMITED (IN) | 2008-09-12 | — | — | WO | disclosed |
| US-6498275-B1 | Use of compounds for the elevation of pyruvate dehydrogenase activity | ASTRAZENECA AB (SE) | 2002-12-24 | — | — | US | disclosed |
| US-5405656-A | Electroless plating; then radiation | NIPPONDENSO CO., LTD. (JP) | 1995-04-11 | — | — | US | disclosed |
| EP-0559216-A1 | Process for producing urethan foam having high-density skin layer | TOSOH CORPORATION (JP) | 1993-09-08 | — | — | EP | disclosed |
| EP-0281036-A2 | A process for preparing a polyarylene thioether | IDEMITSU PETROCHEMICAL CO. LTD. (JP) | 1988-09-07 | — | — | EP | disclosed |
| EP-0034002-A2 | Carboxamidine derivatives | BEECHAM GROUP PLC (GB) | 1981-08-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100105925-A1 | NOVEL PROCESS FOR PREPARATION OF DULOXETINE HYDROCHLORIDE | MAOA, SLC6A3, PNMT | TSHR 844/4885DAO 576/4885NAPRT 785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.